发明授权
US07611713B2 Inducing cellular immune responses to hepatitis B virus using peptide compositions
有权
使用肽组合物诱导对乙型肝炎病毒的细胞免疫应答
- 专利标题： Inducing cellular immune responses to hepatitis B virus using peptide compositions
- 专利标题（中）： 使用肽组合物诱导对乙型肝炎病毒的细胞免疫应答
-
申请号： US10654601申请日： 2003-09-04
-
公开(公告)号： US07611713B2公开(公告)日： 2009-11-03
- 发明人: Alessandro Sette , John Sidney , Scott Southwood , Maria Vitiello , Brian Livingston , Esteban Celis , Ralph Kubo , Howard Grey , Robert Chesnut
- 申请人： Alessandro Sette , John Sidney , Scott Southwood , Maria Vitiello , Brian Livingston , Esteban Celis , Ralph Kubo , Howard Grey , Robert Chesnut
- 申请人地址： US CA San Diego
- 专利权人： Pharmexa Inc.
- 当前专利权人： Pharmexa Inc.
- 当前专利权人地址： US CA San Diego
- 代理机构： Sterne, Kessler, Goldstein & Fox P.L.L.C.
- 主分类号： A61K38/00
- IPC分类号： A61K38/00 ; A61K39/00 ; A61K39/12 ; A61K39/29
摘要：
This invention uses our knowledge of the mechanisms by which antigen is recognized by T cells to develop epitope-based vaccines directed towards HBV. More specifically, this application communicates our discovery of pharmaceutical compositions and methods of use in the prevention and treatment of HBV infection.
公开/授权文献
信息查询
IPC分类:
